Literature DB >> 11606100

The implementation of critical pathways in gynecologic oncology in a managed care setting: a cost analysis.

K Ghosh1, L S Downs, L A Padilla, K P Murray, L B Twiggs, C M Letourneau, L F Carson.   

Abstract

OBJECTIVES: The aim of the study is to determine whether critical pathways can be implemented at an academic institution to limit cost, without compromising patient satisfaction and quality of care. PATIENTS AND METHODS: Patients undergoing a hysterectomy with either cervical or endometrial cancer were placed on specific critical pathways consecutively for an 18-month study period. Preoperative teaching was intensified to educate the patient regarding expectations during the postoperative period. All patients were started on early feeding and patients were also placed on separate care pathways addressing pain and deep vein thrombosis prophylaxis. Total direct costs and patient satisfaction were obtained throughout the study period. During the year prior to care pathway implementation, patient data and direct costs were obtained for the preintervention group utilized for comparison. Postintervention groups were summarized every 6 months during the study period.
RESULTS: From January 1997 through June 1998, 63 patients with cervical carcinoma undergoing a radical hysterectomy (DRG 353) and 21 patients with endometrial cancer who underwent a hysterectomy and lymph node sampling (DRG 355) were utilized as the preintervention group. During the 18-month study period (July 1998-December 1999), 42 patients (DRG 353) and 25 patients (DRG 355) were accrued. The average length of stay was reduced from 5.2 (DRG 353) and 4.7 days (DRG 355) prior to implementation of pathways to 3.4 days in both groups. In addition, total direct costs were reduced by 29 (DRG 353) and 32% (DRG 355) after implementation of care pathways. Patient satisfaction data recorded during the study did not demonstrate any change throughout the study period nor were there any higher rates of readmission after implementation of the care pathways.
CONCLUSIONS: Critical pathways in gynecologic oncology can be implemented in a managed care environment in order to maintain high quality of care, maintain outcomes, and help reduce costs. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11606100     DOI: 10.1006/gyno.2001.6428

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Patient healthcare trajectory. An essential monitoring tool: a systematic review.

Authors:  Jessica Pinaire; Jérôme Azé; Sandra Bringay; Paul Landais
Journal:  Health Inf Sci Syst       Date:  2017-04-12

Review 2.  Outcomes of Enhanced Recovery after Surgery (ERAS) in Gynecologic Oncology: A Review.

Authors:  Steven P Bisch; Gregg Nelson
Journal:  Curr Oncol       Date:  2022-01-28       Impact factor: 3.677

3.  Critical pathways for the management of preeclampsia and severe preeclampsia in institutionalised health care settings.

Authors:  Ricardo Perez-Cuevas; William Fraser; Hortensia Reyes; Daniel Reinharz; Ashi Daftari; Cristina S Heinz; James M Roberts
Journal:  BMC Pregnancy Childbirth       Date:  2003-10-03       Impact factor: 3.007

4.  A stepped strategy that aims at the nationwide implementation of the Enhanced Recovery After Surgery programme in major gynaecological surgery: study protocol of a cluster randomised controlled trial.

Authors:  Jeanny Ja de Groot; José Mc Maessen; Brigitte Fm Slangen; Bjorn Winkens; Carmen D Dirksen; Trudy van der Weijden
Journal:  Implement Sci       Date:  2015-07-30       Impact factor: 7.327

5.  Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Authors:  Mark Pennington; Aleksandra Gentry-Maharaj; Chloe Karpinskyj; Alec Miners; Julie Taylor; Ranjit Manchanda; Rema Iyer; Michelle Griffin; Andy Ryan; Ian Jacobs; Usha Menon; Rosa Legood
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

6.  Effects of oncological care pathways in primary and secondary care on patient, professional and health systems outcomes: a systematic review and meta-analysis.

Authors:  Jolanda C van Hoeve; Robin W M Vernooij; Michelle Fiander; Peter Nieboer; Sabine Siesling; Thomas Rotter
Journal:  Syst Rev       Date:  2020-10-25

7.  Integrated Care Planning for Cancer Patients: A Scoping Review.

Authors:  Anum Irfan Khan; Erin Arthurs; Sharon Gradin; Marnie MacKinnon; Jonathan Sussman; Vishal Kukreti
Journal:  Int J Integr Care       Date:  2017-11-13       Impact factor: 5.120

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.